rHGH and Intestinal Permeability in Intestinal Failure
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
Patients who are being asked to participate in this study have a short small bowel and will
be prescribed to take the medication: Zorbtive® ("Zorbtive/Somatropin/(rHGH)"). Zorbtive® is
an FDA approved recombinant human growth hormone (rHGH). The investigators want to see if
taking this medication improves small bowel function by helping it to take in food,
nutrients, vitamins and minerals. The investigators also believe that if the small bowel is
absorbing food and nutrients better, liver function will improve as well. Therefore, liver
function will also be monitored during the course of the study by performing blood tests.